Enter Note Done
Go to previous page in this tab
Event
  • Presentation | Rethinking DART Testing: Advancing Dev Tox NAMs Through Stakeholder Dialogue
  • Engagement Session
  • Bookmark Icon
  • Applying Developmental Toxicity NAMs in Pharmaceutical Development: Building Regulatory Credibility
  • Schedule
    Notes
  • Room 301‚ Convention Center
    Set Timezone

K. Brannen. Merck & Co., West Point, PA.
Session and Activity Type
Main Session